PFBT
HUMA icon

Parkside Financial Bank & Trust’s Humacyte HUMA Stock Holding History

Parkside Financial Bank & Trust’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-120
Closed -$204 – 2858
2025
Q1 		$204 Buy
+120
New +$451 ﹤0.01% 2677

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Parkside Financial Bank & Trust's HUMA Position: Q2 2025 in Review

Parkside Financial Bank & Trust sold out of Humacyte (HUMA) in Q2 2025, closing a stake of 120 shares — an estimated $204 sold.

Parkside Financial Bank & Trust first reported a position in HUMA in Q1 2025 and held it in 1 quarter. The position peaked at $204 in Q1 2025. 156 funds tracked by Wall St. Rank hold HUMA as of Q2 2025.

  • Parkside Financial Bank & Trust reported no remaining Humacyte position as of Q2 2025 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 120 Humacyte shares in Q2 2025, an estimated $204.
  • Parkside Financial Bank & Trust first reported a position in Humacyte in Q1 2025 and held it in 1 quarter.
  • Parkside Financial Bank & Trust's Humacyte position peaked at $204 in Q1 2025.
  • 156 funds tracked by Wall St. Rank held Humacyte as of Q2 2025.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2025, filed 7 Aug 2025.